When it comes to successful preclinical testing of medical devices, experience matters. NAMSA has amassed the largest breadth and depth of therapeutic expertise and knowledge than any other preclinical development partner in the industry. NAMSA’s preclinical research services support all model types, treatments and implant requirements, including Cardiovascular, Dental, Dermal, Electrophysiology, Gastrointestinal, Neuromodulation, Orthopedics, Pulmonary, Urogenital, Wound Healing and several others.
Our highly sought-after global teams are experts at helping Sponsors utilize data to bridge preclinical safety endpoints to proposed clinical endpoints, allowing clinical labs to standardize measurements and obtain expert interpretations of results. NAMSA can also support early feasibility testing with non-GLP surgical studies intended to provide iteration and proof-of-concept prior to an investment in GLP programs.
To help further support Sponsor goals, we keep cutting-edge imaging technology at the heart of all preclinical research services, including diagnostic imaging for visualizing implants, diagnosing defects or disease, and documenting research outcomes. In addition, NAMSA’s surgical staff, Doctors of Veterinary Medicine and/or Academy of Surgical Research-certified, are equipped with the necessary tools to support your entire procedure or to fill in specific procedural role gaps so you may focus on other research responsibilities during implant or treatment procedures. When you need thorough preclinical testing of medical devices, NAMSA’s team is here to provide the expertise.